ConductScience.org, home

Paper · 6973760

Expression of cell surface markers after human B lymphocyte activation.

Stashenko P and 3 others. Proc Natl Acad Sci U S A, 1981. Cited by 244 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Expression of cell surface markers after human B lymphocyte activation. Papers, record 6973760. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6973760

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Expression of cell surface markers after human B lymphocyte activation.
PubMed
Journal
Proc Natl Acad Sci U S A
PubMed
Year
1981
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
244
iCite
Relative citation ratio, by iCite
5.26
iCite
Revised in PubMed
2020-12-22
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Stashenko PP
2Nadler LML M
3Hardy RR
4Schlossman SFS F

Source PubMed

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antibody-Producing CellsMajor topic
Antigens, SurfaceMajor topic
B-LymphocytesMajor topic
Cell Differentiation
Cytoplasm
Humans
Immunoglobulins
Lymphocyte Activation
Lymphoid Tissue
Phenotype
Pokeweed Mitogens
Tissue Distribution

Source PubMed

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
AI 12069NIAID NIH HHSUnited StatesR01AI012069PubMed and NIHNIH RePORTER
CA 19589NCI NIH HHSUnited StatesP01CA019589PubMed and NIHNIH RePORTER
DE-04881NIDCR NIH HHSUnited StatesP50DE004881PubMed and NIHNIH RePORTER
R37AI012069NIHNIH RePORTER

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References34

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
11,092,758Development of B lymphocytes. I. Cell populations and a critical event during ontogeny.J Immunol1975https://conductscience.org/library/papers/1092758PubMed
26,944,297Monoclonal antibodies defining serologically distinct HLA-D/DR related Ia-like antigens in man.Hum Immunol1981https://conductscience.org/library/papers/6944297PubMed
31,097,506The expression on mouse lymphoid cells of Th-B, an antigen common to mouse B cells and thymus cells.J Immunol1975https://conductscience.org/library/papers/1097506PubMed
4810,058Membrane-associated immunoglobulin determinants on bone marrow and blood lymphocytes in the pediatric age group and on fetal tissues.Ann N Y Acad Sci1975https://conductscience.org/library/papers/810058PubMed
51,062,806Ontogeny of lymphocyte subpopulations in human fetal liver.Proc Natl Acad Sci U S A1976https://conductscience.org/library/papers/1062806PubMed
61,083,069Immunoglobulin-receptors revisited.Science1975https://conductscience.org/library/papers/1083069PubMed
71,083,418The class of surface immunoglobulin on cells carrying IgG memory in rat thoracic duct lymph: the size of the subpopulation mediating IgG memory.J Exp Med1976https://conductscience.org/library/papers/1083418PubMed
81,083,879B lymphocyte differentiation induced by lipopolysaccharide. III. Suppression of B cell maturation by anti-mouse immunoglobulin antibodies.J Immunol1976https://conductscience.org/library/papers/1083879PubMed
91,084,527Ontogeny of murine B lymphocytes: sequence of B-cell differentiation from surface-immunoglobulin-negative precursors to plasma cells.Proc Natl Acad Sci U S A1976https://conductscience.org/library/papers/1084527PubMed
10824,081Assessment of a B-cell function in chronic lymphocytic leukemia.Clin Immunol Immunopathol1976https://conductscience.org/library/papers/824081PubMed

Cited by60

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 244 citations.

PMIDTitleJournalYearIn PapersSource
41,820,782Impact of Anti-CD20 Therapies on Cytokine, Chemokine and Adhesion Molecule Dynamics in Multiple Sclerosis: A Narrative Review.Neurol Ther2026https://conductscience.org/library/papers/41820782PubMed
41,269,450Exploring the Role of B-Cell Biotherapy in Myasthenia Gravis from a Genetic Perspective: A Mendelian Randomization Study.Mol Neurobiol2025https://conductscience.org/library/papers/41269450PubMed
37,081,097Regulation of early diagnosis and prognostic markers of lung adenocarcinoma in immunity and hypoxia.Sci Rep2023https://conductscience.org/library/papers/37081097PubMed
33,880,738A Milestone in Multiple Sclerosis Therapy: Monoclonal Antibodies Against CD20-Yet Progress Continues.Neurotherapeutics2021https://conductscience.org/library/papers/33880738PubMed
33,352,466MS4A1 expression and function in T cells in the colorectal cancer tumor microenvironment.Cell Immunol2021https://conductscience.org/library/papers/33352466PubMed
33,081,391Facts and Challenges in Immunotherapy for T-Cell Acute Lymphoblastic Leukemia.Int J Mol Sci2020https://conductscience.org/library/papers/33081391PubMed
31,494,742Presence of T cells directed against CD20-derived peptides in healthy individuals and lymphoma patients.Cancer Immunol Immunother2019https://conductscience.org/library/papers/31494742PubMed
30,967,621B cell checkpoints in autoimmune rheumatic diseases.Nat Rev Rheumatol2019https://conductscience.org/library/papers/30967621PubMed
30,050,376Treating primary-progressive multiple sclerosis: potential of ocrelizumab and review of B-cell therapies.Degener Neurol Neuromuscul Dis2017https://conductscience.org/library/papers/30050376PubMed
29,593,838B cell-based therapies in CNS autoimmunity: differentiating CD19 and CD20 as therapeutic targets.Ther Adv Neurol Disord2018https://conductscience.org/library/papers/29593838PubMed

1 to 10 of 60

See all 60 cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
GRPR2,925PubTator's text mininghttps://conductscience.org/library/genes/2925NCBI Gene
MS4A1931PubTator's text mininghttps://conductscience.org/library/genes/931NCBI Gene

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/6973760

GET https://conductscience.org/api/papers/v1/6973760/references?page=2